← Back to Browse
ProductDiagnostic Tests

Hereditary Tumor Gene Detection Test

China

Genetic screening for hereditary cancer susceptibility genes including BRCA and other tumor suppressors. This test enables early identification of high-risk individuals for surveillance.

Manufactured by

PreceDo Pharmaceuticals Co.Ltd.

China

PreceDo Pharmaceuticals is a state-controlled high-tech enterprise established in 2015, affiliated with Chinese Academy of Sciences Hefei Institute. The company specializes in cell engineering technology, featuring proprietary HDS tumor precision medication technology, Ba/F3 cancer kinase target engineered cell library, and an approved renewable cancer primary cell biobank for anti-tumor drug development and clinical precision treatment.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
59 relevant products
2United States
7 relevant products
3South Korea
6 relevant products
🔒

16 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 109 closest product alternatives

109 products

106 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products